Zicam sponsors NYC marathon
NEW YORK Matrixx Initiatives Tuesday morning announced that Zicam Cold Remedy will be the official homeopathic cold remedy of the ING New York City Marathon.
Matrixx Initiatives will be exhibiting at the ING New York City Marathon Health and Fitness Expo at the Jacob Javits Convention Center Nov. 1 through 3.
Chris Carmichael, author and coach to seven-time Tour-De-France winner Lance Armstrong, will be on hand to meet with attendees and offer fitness advice.
“We are proud to sponsor the ING New York City Marathon, an event which enables us to reach so many professional and recreational athletes,” stated Tim Connors, vice president of marketing, Matrixx Initiatives. “Zicam Cold Remedy is perfect for anyone with an active lifestyle—from Olympic hopefuls to moms on the go, because it is clinically proven to lessen the severity of cold symptoms and shorten the duration of the cold when taken within the first 24 to 48 hours after symptom onset.”
“When training for a major athletic endurance event, the rule of thumb is one week off equates to two to three weeks of lost fitness,” Carmichael said. “Zicam Cold Remedy can help prevent spoilers like the common cold from ruining a big event that you’ve worked hard for, such as a marathon or an important business meeting.”
The ING New York City Marathon is the premier event of New York Road Runners. This year, more than 37,000 runners from all 50 states and over 100 countries will participate. Race day is Nov. 4.
Next, LaValle announce positive results from Seditol study
SALINAS, Calif. Next Pharmaceuticals and The LaValle Metabolic Institute last week announced the results of a clinical study on Seditol, concluding that the natural formulation provides relaxation, promotes restful sleep and helps reduce fatigue due to lack of sleep with minimal side effects.
“I believe that Seditol is a great alternative for people who are interested in a natural approach to managing sleeplessness,” stated Charles Kosmont, chief executive officer and president of Next Pharmaceuticals. “Exhausted Americans filled almost 50 million prescriptions for sleeping pills last year.”
The open-label, single-center trial of 773 people was completed by the LaValle Metabolic Institute in Cincinnati. Of those, 718 reported that Seditol helped them relax; 680 reported Seditol helped them have a restful night’s sleep; and 696 reported Seditol helped reduce fatigue due to lack of sleep.
Warburg Pincus completes B&L acquisition
ROCHESTER, N.Y. Bausch & Lomb and Warburg Pincus on Friday announced that Warburg Pincus has completed the acquisition of B&L for a total purchase price of approximately $4.5 billion, including the assumption of approximately $830 million in debt.
The company’s stock ceased trading on the New York Stock Exchange and was delisted by close of market Friday, the company announced.
“With a strong and supportive partner in Warburg Pincus, we are well-positioned to create new opportunities for Bausch & Lomb and advance our leadership in the eye health industry,” stated Ronald Zarrella, chairman and chief executive officer of B&L. “Our customers will continue to receive high levels of service, product quality and innovation, and our commitment to serving their needs remains steadfast.”